αI-spectrin represents evolutionary optimization of spectrin for red blood cell deformability.
Journal
Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626
Informations de publication
Date de publication:
07 09 2021
07 09 2021
Historique:
received:
22
03
2021
revised:
21
07
2021
accepted:
28
07
2021
pubmed:
6
8
2021
medline:
29
10
2021
entrez:
5
8
2021
Statut:
ppublish
Résumé
Spectrin tetramers of the membranes of enucleated mammalian erythrocytes play a critical role in red blood cell survival in circulation. One of the spectrins, αI, emerged in mammals with enucleated red cells after duplication of the ancestral α-spectrin gene common to all animals. The neofunctionalized αI-spectrin has moderate affinity for βI-spectrin, whereas αII-spectrin, expressed in nonerythroid cells, retains ancestral characteristics and has a 10-fold higher affinity for βI-spectrin. It has been hypothesized that this adaptation allows for rapid make and break of tetramers to accommodate membrane deformation. We have tested this hypothesis by generating mice with high-affinity spectrin tetramers formed by exchanging the site of tetramer formation in αI-spectrin (segments R0 and R1) for that of αII-spectrin. Erythrocytes with αIIβI presented normal hematologic parameters yet showed increased thermostability, and their membranes were significantly less deformable; under low shear forces, they displayed tumbling behavior rather than tank treading. The membrane skeleton is more stable with αIIβI and shows significantly less remodeling under deformation than red cell membranes of wild-type mice. These data demonstrate that spectrin tetramers undergo remodeling in intact erythrocytes and that this is required for the normal deformability of the erythrocyte membrane. We conclude that αI-spectrin represents evolutionary optimization of tetramer formation: neither higher-affinity tetramers (as shown here) nor lower affinity (as seen in hemolytic disease) can support the membrane properties required for effective tissue oxygenation in circulation.
Identifiants
pubmed: 34352252
pii: S0006-3495(21)00637-8
doi: 10.1016/j.bpj.2021.07.027
pmc: PMC8456306
pii:
doi:
Substances chimiques
Spectrin
12634-43-4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3588-3599Subventions
Organisme : NIDDK NIH HHS
ID : P01 DK032094
Pays : United States
Informations de copyright
Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.
Références
Sci Rep. 2019 May 1;9(1):6771
pubmed: 31043643
J Biol Chem. 1983 Dec 25;258(24):14938-47
pubmed: 6654896
Hematology Am Soc Hematol Educ Program. 2005;:13-8
pubmed: 16304353
Biochemistry. 1997 Jun 10;36(23):6977-85
pubmed: 9188694
J Clin Pathol. 1963 Jul;16:377-82
pubmed: 14044042
J Biol Chem. 1996 Mar 22;271(12):6636-44
pubmed: 8636080
Phys Rev Lett. 2007 Feb 16;98(7):078301
pubmed: 17359066
Physiol Rev. 2001 Jul;81(3):1353-92
pubmed: 11427698
J Biol Chem. 2002 Aug 30;277(35):31796-800
pubmed: 12105217
Phys Rev Lett. 2007 May 4;98(18):188302
pubmed: 17501614
Biophys J. 1990 Apr;57(4):865-75
pubmed: 2344469
J Clin Invest. 1981 Sep;68(3):597-605
pubmed: 7276161
Biochemistry. 1986 Oct 7;25(20):5969-75
pubmed: 3790499
J Clin Invest. 1988 Aug;82(2):617-23
pubmed: 3403720
J Lab Clin Med. 1996 Sep;128(3):259-69
pubmed: 8783633
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):643-8
pubmed: 16407147
Science. 1994 Nov 11;266(5187):1032-5
pubmed: 7973655
PLoS Comput Biol. 2017 Oct 9;13(10):e1005790
pubmed: 28991926
Semin Hematol. 2004 Apr;41(2):118-41
pubmed: 15071790
Blood. 2008 Nov 15;112(10):4298-307
pubmed: 18723693
Blood. 2008 Nov 15;112(10):3939-48
pubmed: 18988878
Biochem J. 2003 Sep 15;374(Pt 3):613-24
pubmed: 12820899
Biophys J. 1996 Oct;71(4):1680-94
pubmed: 8889146
Jpn J Physiol. 1982;32(1):25-33
pubmed: 7077891
Biophys J. 1990 Apr;57(4):877-82
pubmed: 2344470
J Clin Invest. 1947 Jul;26(4):636-40
pubmed: 16695456
Blood. 1982 May;59(5):900-5
pubmed: 7074218
Biorheology. 2016;53(5-6):237-249
pubmed: 28222499
Eur J Biochem. 1978 Aug 1;88(2):379-85
pubmed: 689023
Scand J Clin Lab Invest. 2009;69(7):777-88
pubmed: 19929721
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20808-13
pubmed: 23213229
Biochem Cell Biol. 2011 Apr;89(2):200-15
pubmed: 21455271
Blood. 2016 Jan 14;127(2):187-99
pubmed: 26537302
J Am Assoc Lab Anim Sci. 2011 Sep;50(5):680-5
pubmed: 22330715
Biophys J. 2018 Apr 24;114(8):2014-2023
pubmed: 29694877
Genetics. 2005 Feb;169(2):1157-64
pubmed: 15654095
J Mol Biol. 2014 Jan 9;426(1):21-35
pubmed: 24055379
Biophys J. 1998 Sep;75(3):1584-97
pubmed: 9726959
Br J Haematol. 1975 Apr;29(4):537-43
pubmed: 1191563
Blood. 1987 Jan;69(1):156-9
pubmed: 3790722
Biophys J. 1997 May;72(5):2369-81
pubmed: 9129841
Clin Chem. 1980 Sep;26(10):1435-42
pubmed: 6996869
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Science. 1993 Dec 24;262(5142):2027-30
pubmed: 8266097
Biochim Biophys Acta. 1998 May 19;1384(2):396-404
pubmed: 9659401
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1911-5
pubmed: 6940197
Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jan;77(1 Pt 2):016310
pubmed: 18351937
Biochim Biophys Acta. 1985 Aug 8;830(2):147-58
pubmed: 2410030
Clin Hemorheol Microcirc. 2011;47(3):229-39
pubmed: 21498902
Philos Trans R Soc Lond B Biol Sci. 2017 Feb 5;372(1713):
pubmed: 27994121